Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2025-05-01
DOI
https://doi.org/10.1136/bmjopen-2024-097981
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study

António Ferreira, Lia Bally, Marc Y. Donath, David Herzig et al.
1 citations
BMJ Open
Diabetes Treatment and Management
1.29
article

Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study

António Ferreira, Lia Bally, Marc Y. Donath, David Herzig, Matthias Hepprich, Justus Fischer, Marco Cattaneo
article en
1 citations

Abstract

No abstract available for this paper.
BMJ OpenVol. 15(5)
University of Basel (CH), University Hospital of Bern (CH), University Hospital of Basel (CH), Department of Biomedicine Basel (CH), Kantonsschule Olten (CH)
Zero hunger
Openalex Percentile: Top 19%
Diabetes Treatment and Management
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.